Page last updated: 2024-10-31

5-methylfurtrethonium and Lung Diseases, Obstructive

5-methylfurtrethonium has been researched along with Lung Diseases, Obstructive in 1 studies

5-methylfurtrethonium: RN given refers to parent cpd; structure

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Koppen, CJ1
Lammers, JW1
Rodrigues de Miranda, JF1
Beld, AJ1
van Herwaarden, CL1
van Ginneken, CA1

Other Studies

1 other study available for 5-methylfurtrethonium and Lung Diseases, Obstructive

ArticleYear
Muscarinic receptor binding in central airway musculature in chronic airflow obstruction.
    Pulmonary pharmacology, 1989, Volume: 2, Issue:3

    Topics: Aged; Bronchi; Humans; In Vitro Techniques; Lung Diseases, Obstructive; Middle Aged; Muscarine; Musc

1989